title: Is Vorapaxar a safe and effective antiplatelet agent for patients with prior ischaemic stroke receiving standard antiplatelet therapy?
authors.forename: Kiran
authors.initials: K
authors.lastname: Aftab
authors.forename: Ayeesha Kamran
authors.initials: AK
authors.lastname: Kamal
mesh_terms: D005260:Female; D006801:Humans; D020300:Intracranial Hemorrhages / Q000453:epidemiology*; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy*
chemical_list: D007783:Lactones; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines